John Sharkey
Corporate Officer/Principal chez GEOVAX LABS, INC.
Fortune : 348 $ au 31/05/2024
Profil
John W.
Sharkey is the founder of Cogas Consulting LLC, which was founded in 2010.
Currently, he is the Vice President-Business Development at GeoVax Labs, Inc. He has previously worked as the Chief Executive Officer at Largent Health LLC, Director at Sunridge International, Inc., VP-Business Development & Alliance Management at Shionogi Pharma, Inc., and Head-Business Development at Iconic Therapeutics, Inc. Dr. Sharkey holds a doctorate degree from the State University of New York at Buffalo and an undergraduate degree from The State University of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GEOVAX LABS, INC.
0,01% | 01/08/2023 | 191 ( 0,01% ) | 348 $ | 31/05/2024 |
Postes actifs de John Sharkey
| Sociétés | Poste | Début |
|---|---|---|
| GEOVAX LABS, INC. | Corporate Officer/Principal | 13/06/2022 |
Anciens postes connus de John Sharkey
| Sociétés | Poste | Fin |
|---|---|---|
| Cogas Consulting LLC | Fondateur | - |
| Largent Health LLC | Directeur Général | - |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Corporate Officer/Principal | - |
| SUNRIDGE INTERNATIONAL, INC. | Directeur/Membre du Conseil | - |
Formation de John Sharkey
| State University of New York at Buffalo | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SUNRIDGE INTERNATIONAL, INC. | Health Technology |
| GEOVAX LABS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
| Largent Health LLC | |
| Cogas Consulting LLC |
